Fidelis Insurance Holdings Ltd. FIHL 深 滬
已收盤 08-01 16:00:00 美东时间
14.87
-0.240
-1.59%
華盛通- 最 高15.125
- 今 開15.11
- 成交量 60.36万股
- 最 低 14.80
- 昨 收 15.11
- 總市值 16.36亿
- 52周最高 21.02
- 市盈率 靜 15.18
- 換手率 0.00%
- 52周最低 13.97
- 委 比 70.83%
- 總股本 1.10亿
- 歷史最高 21.02
- 量 比 1.17
- 振 幅 2.15%
- 歷史最低 10.95
- 每 手 1
- 風險率 2.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅336.36%！Canaccord Genuity上调ATAI Life Sciences目标价至12美元，维持"买入"评级
Redburn Atlantic：下调Adobe(ADBE)评级至"卖出"，目标价从420美元降至280美元
07-03 11:01
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
Keefe, Bruyette & Woods Maintains Outperform on Fidelis Insurance Hldgs, Raises Price Target to $21
Keefe, Bruyette & Woods analyst Meyer Shields maintains Fidelis Insurance Hldgs (NYSE:FIHL) with a Outperform and raises the price target from $20 to $21.
07-02 01:43
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
JMP Securities Maintains Market Outperform on Fidelis Insurance Hldgs, Raises Price Target to $27
JMP Securities analyst Matthew Carletti maintains Fidelis Insurance Hldgs (NYSE:FIHL) with a Market Outperform and raises the price target from $24 to $27.
05-16 23:58
Fidelis Insurance Releases Q1 2025 Financial Results
Fidelis Insurance Holdings Ltd. ( ($FIHL) ) has provided an update. On May 15, ...
05-16 04:27
Fidelis Insurance Hldgs Q1 Adj. EPS $(0.41), Inline, Sales $658.40M Miss $927.63M Estimate
Fidelis Insurance Hldgs (NYSE:FIHL) reported quarterly losses of $(0.41) per share which met the analyst consensus estimate. This is a 155.41 percent decrease over earnings of $0.74 per share from the same period last
05-15 04:15
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
美股大行评级 | 潜在涨幅223.78%！内克塔治疗获杰富瑞升目标价至2美元，上调至"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117736711687032832.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 杰富瑞：上调内克塔治疗(NKTR)评级至"买入"，目标价从1美元升至2美元</p> <p>• Roth MKM：维持Lovesac Co.(LOVE)"买入"评级，目标价从22美元升至28美元</p> <p>• Macq
04-14 07:05
